Differential oxidative stress levels in mothers with preeclampsia delivering male and female babies

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 16, 2015, Pages 1973-1980

  Roy, Suchitra ^a   Dhobale, Madhavi ^a   Dangat, Kamini ^a   Mehendale, Savita ^b   Lalwani, Sanjay ^b   Joshi, Sadhana ^a  

^a Bharati Vidyapeeth   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

Fetal programming; glutathione peroxidase; malondialdehyde; reactive oxygen species; superoxide dismutase

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BABY; CHILDBIRTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; GROWTH CURVE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; OXIDATIVE STRESS; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; CASE CONTROL STUDY; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; SEX DIFFERENCE;

ADULT; ANTIOXIDANTS; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SEX FACTORS;

EID: 84942745902     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.974537     Document Type: Article

References (45)

1. Conti E, Zezza L, Ralli E, et al. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? Cytokine Growth Factor Rev 2013; 24: 411-25
2. Anderson UD, Olsson MG, Kristensen KH, et al. Review: biochemical markers to predict preeclampsia. Placenta 2012; 33: S42-7
3. Rinaudo P, Wang E. Fetal programming and metabolic syndrome. Annu Rev Physiol 2012; 74: 107-30
4. Wu CS, Nohr EA, Bech BH, et al. Diseases in children born to mothers with preeclampsia: a population-based sibling cohort study. Am J Obstet Gynecol 2011; 204: 157.e1-5
5. Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006; 45: 189-200
6. Poljsak B. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011; 2011: 194586
7. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 2011; 15: 1911-26
8. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008; 266: 6-11
9. Thompson LP, Al-Hasan Y. Impact of oxidative stress in fetal programming. J Pregnancy 2012; 2012: 582748
10. Luo ZC, Xiao L, Nuyt AM. Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J Diabetes 2010; 1: 89-98
11. Hsieh TT, Chen SF, Lo LM, et al. The association between maternal oxidative stress at mid-gestation and subsequent pregnancy complications. Reprod Sci 2012; 19: 505-12
12. Min J, Park B, Kim YJ, et al. Effect of oxidative stress on birth sizes: consideration of window from mid pregnancy to delivery. Placenta 2009; 30: 418-23
13. Park H, Kim YJ, Lee HY, et al. A trial for association between oxidative stress in midterm pregnancy and postnatal growth during the first year of life. Korean J Epidemiol 2004; 26: 17-26
14. DeBoer MD, Lima AA, Oría RB, et al. Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome? Nutr Rev 2012; 70: 642-53
15. Gale CR, Martyn CN. Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry 2004; 184: 28-33
16. Vinall J, Grunau RE, Brant R, et al. Slower postnatal growth is associated with delayed cerebral cortical maturation in preterm newborns. Sci Transl Med 2013; 5: 168ra8
17. Mehendale S, Kilari A, Dangat K, et al. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynaecol Obstet 2008; 100: 234-8
18. Kulkarni A, Mehendale S, Pisal H, et al. Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. Clin Nutr 2011; 30: 60-4
19. Roberts JM, Catov JM. Preeclampsia more than 1 disease: or is it? Hypertension 2008; 51: 989-90
20. Kulkarni A, Chavan-Gautam P, Mehendale S, et al. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol 2011; 30: 79-84
21. Sundrani DP, Reddy US, Joshi AA, et al. Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin Epigenetics 2013; 5: 6
22. Reynolds SA, Roberts JM, Bodnar LM, et al. Newborns of preeclamptic women show evidence of sex-specific disparity in fetal growth. Gend Med 2012; 9: 424-35
23. Gabory A, Roseboom TJ, Moore T, et al. Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ 2013; 4: 5
24. D'Souza VA, Kilari AS, Joshi AA, et al. Differential regulation of brain-derived neurotrophic factor in term and preterm preeclampsia. Reprod Sci 2014; 21: 230-5
25. Kulkarni AV, Mehendale SS, Yadav HR, et al. Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res 2010; 33: 561-7
26. Dangat KD, Mehendale SS, Yadav HR, et al. Long-chain polyunsaturated fatty acid composition of breast milk in pre-eclamptic mothers. Neonatology 2010; 97: 190-4
27. Siddiqui IA, Jaleel A, Al'Kadri HM, et al. Biomarkers of oxidative stress in women with pre-eclampsia. Biomark Med 2013; 7: 229-34
28. Gohil JT, Patel PK, Gupta P. Evaluation of oxidative stress and antioxidant defence in subjects of preeclampsia. J Obstet Gynaecol India 2011; 61: 638-40
29. Atamer Y, Koçyigit Y, Yokus B, et al. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 119: 60-6
30. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122: 369-82
31. Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294: H541-50
32. Bulgan Kilicdag E, Ay G, Celik A, et al. Oxidant-antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia. Hypertens Pregnancy 2005; 24: 147-57
33. Peraçoli MT, Bannwart CF, Cristofalo R, et al. Increased reactive oxygen species and tumor necrosis factor-alpha production by monocytes are associated with elevated levels of uric acid in pre-eclamptic women. Am J Reprod Immunol 2011; 66: 460-7
34. Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008; 313: 37-44
35. Llurba E, Gratacós E, Martín-Gallán P, et al. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004; 37: 557-70
36. Dordević NZ, Babić GM, Marković SD, et al. Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women. Reprod Toxicol 2008; 25: 213-18
37. Bayhan G, Atamer Y, Atamer A, et al. Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia. Clin Exp Obstet Gynecol 2000; 27: 142-6
38. Yildirim A, Altinkaynak K, Aksoy H, et al. Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell Biochem Funct 2004; 22: 213-17
39. Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010; 5: 51-66
40. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84
41. Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 2011; 12: 1008-13
42. Vina J, Gambini J, Lopez-Grueso R, et al. Females live longer than males: role of oxidative stress. Curr Pharm Des 2011; 17: 3959-65
43. Kwong WY, Wild AE, Roberts P, et al. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 2000; 127: 4195-202
44. Gould DA, Moscoso GJ, Young MP, Barton DP. Human first trimester fetal ovaries express oncofetal antigens and steroid receptors. J Soc Gynecol Investig 2000; 7: 131-8
45. Ahn Y, Garruto RM. Weight variation by sex and nature of risk factors in high-risk infants: an evolutionary perspective. Coll Antropol 2007; 31: 937-41